ClinicalTrials.Veeva

Menu

Venous Congestion and Organ Dysfunction. (CoDoRéa)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Organ Dysfunction Syndrome
Venous Congestion

Treatments

Other: collection of echographic parameters
Other: collection of clinical parameters
Other: collection of biological parameters

Study type

Observational

Funder types

Other

Identifiers

NCT04680728
GUINOT 2020

Details and patient eligibility

About

Venous congestion, which is a phenomenon described in cardiology and post-operative cardiac surgery, is responsible for an increase in morbidity and mortality.

Indeed, it can lead to kidney failure, liver failure, prolonged ileus, scarring complications, and neurological disorders. Clinical and ultrasound indications have been described to diagnose this condition.

To date, this phenomenon is poorly known and not described in intensive care patients outside the cardiac context. However, intensive care patients can present the risk factors associated with the occurrence of congestion: acute cardiac failure, significant water-salt overload, and/or fluid distribution anomalies. Thus, observational studies have found an association between the input-output balance, the quantity of salt-water intake, the presence of right heart dysfunction and the occurrence of acute kidney failure, digestive disorders, hypoxemia and a prolonged stay in intensive care. The presence of a congestive condition is medically treatable since diuretic decongestion is associated with improved cardiac outcomes.

It is therefore necessary, in an intensive care context, to be able to define and diagnose this state of venous congestion, to study its prevalence, and to confirm the existence of a link with organ failure in order to pave the way to known adapted treatment options.

Enrollment

185 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult
  • Patient who has expressed his or her non-opposition to the collection of data (or the health care proxy, or a close relative if the patien is unable to receive the information)
  • Patient admitted to intensive care for less than 24 hours.

Exclusion criteria

  • Person not affiliated to the national health insurance
  • Minor, protected major
  • Pregnant or breastfeeding women
  • Anechogenicity confirmed by the operator
  • Chronic atrial fibrillation
  • Mechanical cardiac assistance
  • Uncontrolled blood pressure (MAP < 65 mmHg)

Trial design

185 participants in 1 patient group

patient
Description:
Patient admitted to intensive care for less than 24 hours.
Treatment:
Other: collection of biological parameters
Other: collection of clinical parameters
Other: collection of echographic parameters

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems